Free tool
Healthcare stocks
We cover 36 companies in the Healthcare sector. The median market value in the group is $69.23M. Across the group, the median move over the past trading day is +1.06%. 47% of the 36 with a 200-day average trade above it. Price change over the past year runs from −64.1% to +57.8% across the middle 80 percent of the group, with a median of −10.6%.
Other lists in this group
Table
36 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +73.55% | Oct 29, 2026 |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% | Oct 13, 2026 |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +32.34% | Oct 29, 2026 |
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% | Oct 29, 2026 |
| NOT.DE | Novartis AG | $300.14B | Mega cap | +28.89% | Oct 27, 2026 |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +5.65% | Oct 30, 2026 |
| AZN.ST | AstraZeneca PLC | $258.56B | Mega cap | +6.22% | Oct 30, 2026 |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% | Nov 3, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% | Oct 21, 2026 |
| NVO.WA | Novo Nordisk A/S | $212.23B | Mega cap | −9.22% | Nov 4, 2026 |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | −11.26% | Nov 4, 2026 |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +15.22% | Nov 4, 2026 |
| ABL.DE | Abbott Laboratories | $200.44B | Mega cap | −10.02% | Oct 14, 2026 |
| NANOFH.HE | Nanoform Finland Oyj | $95.78M | Micro cap | +15.66% | Nov 11, 2026 |
| NANOFS.ST | Nanoform Finland Oyj | $93.63M | Micro cap | +19.56% | Nov 11, 2026 |
| VISTN.OL | Vistin Pharma ASA | $91.60M | Micro cap | −15.42% | Oct 29, 2026 |
| OSE.PA | OSE Immunotherapeutics SA | $88.75M | Micro cap | −47.94% | Sep 28, 2026 |
| ZLNA.OL | Zelluna ASA | $70.31M | Micro cap | +56.57% | Nov 5, 2026 |
| ONCO.ST | Oncopeptides AB (publ) | $68.14M | Micro cap | −67.92% | Aug 27, 2026 |
| LYTIX.OL | Lytix Biopharma ASA | $64.69M | Micro cap | −4.19% | Aug 27, 2026 |
| SEZI.ST | Senzime AB (publ) | $61.48M | Micro cap | −39.98% | Oct 29, 2026 |
| BACTI-B.ST | Bactiguard Holding AB (publ) | $52.93M | Micro cap | −46.25% | Oct 22, 2026 |
| CANTA.ST | Cantargia AB (publ) | $51.16M | Micro cap | −27.38% | Nov 25, 2026 |
| AIFORIA.HE | Aiforia Technologies Oyj | $49.78M | Micro cap | −60.34% | Aug 28, 2026 |
| ORX.ST | Orexo AB (publ) | $48.90M | Micro cap | −35.06% | Oct 22, 2026 |
| OSSD.ST | OssDsign AB (publ) | $44.89M | Micro cap | −73.26% | Nov 3, 2026 |
| ONCIN.OL | Oncoinvent ASA | $43.71M | Micro cap | +10.90% | Aug 27, 2026 |
| OPTOMED.HE | Optomed Oyj | $41.93M | Micro cap | −54.39% | Nov 6, 2026 |
| IVACC.ST | Intervacc AB (publ) | $38.50M | Micro cap | +4.78% | Nov 12, 2026 |
| NAVA.OL | Navamedic ASA | $37.60M | Micro cap | −32.27% | Oct 29, 2026 |
| PSH0.DE | Sernova Biotherapeutics Inc | $30.82M | Micro cap | −27.68% | Sep 10, 2026 |
| CONTX.OL | ContextVision AB (publ) | $28.31M | Micro cap | −21.11% | Aug 27, 2026 |
| INTEG-B.ST | Integrum AB (publ) | $24.72M | Micro cap | −79.55% | Sep 3, 2026 |
| AELIS.PA | Aelis Farma SA | $16.34M | Micro cap | −19.22% | Sep 15, 2026 |
| VIVE.ST | Vivesto AB | $10.39M | Micro cap | −57.13% | Nov 12, 2026 |
| EXPRS2.ST | ExpreS2ion Biotech Holding AB (publ) | $3.19M | Micro cap | −93.99% | Nov 12, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.